glp 1 allodynia Ozempic-like drugs may cause skin pain, says weight loss doctor Advances in GLP-1 receptor agonists

This study specifically examined oral semaglutide, which has additional absorption concerns because it is taken by mouth daily rather than injected weekly

Improved diastolic function in type 2 diabetes after a six month liraglutide treatment

Changes to GLP-1 Medication Coverage The Centers for Medicare & Medicaid Services (CMS) has proposed changes to Medicare and Medicaid coverage for glucagon-like peptide-1 (GLP-1) medications, which are currently covered primarily for the treatment of type 2 diabetes

More frequent eye exams help us catch problems during this transition period

Warning Letters to Telehealth providers marketing GLP-1 compounded On March 3rd, FDA sent multiple sets of warnings to 30 Telehealth companies offering GLP-1s on their websites warning them to refrain from improperly using a brand when they are not the compounder or claiming equivalency to FDA approved drugs